Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05312047
Other study ID # PR(AMI)631-2021
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date April 4, 2022
Est. completion date January 2025

Study information

Verified date May 2024
Source Hospital Universitari Vall d'Hebron Research Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Urinary incontinence after surgical correction of pelvic organ prolapse (POP) could occur. This is a condition that decreases both patients' satisfaction and quality of life. Reports on the prevalence of urinary incontinence after POP surgery are controversial. Concomitant surgery for incontinence could reduce this prevalence, whereas it increases treatment costs and the likelihood of surgical complications. Therefore, it is of paramount importance to know the exact prevalence of urinary incontinence after POP surgery in our population and the potential risk factors associated with this condition.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 609
Est. completion date January 2025
Est. primary completion date January 2025
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria: - Women who will undergo vaginal surgery for pelvic organ prolapse. Exclusion Criteria: - Inability to give consent to the study.

Study Design


Intervention

Procedure:
Pelvic organ prolapse surgery
Vaginal surgery of any compartment for pelvic organ prolapse

Locations

Country Name City State
Spain Hospital Germans Trias i Pujol Badalona Barcelona
Spain Hospital de Sant Pau Barcelona
Spain Hospital del Mar Barcelona
Spain Vall d'Hebron Barcelona Hospital Campus Barcelona
Spain Hospital Santa Caterina Girona
Spain Hospital General de Granollers Granollers Barcelona
Spain Hospital General de l'Hospitalet Hospitalet de Llobregat Barcelona
Spain Hospital d'Igualada Igualada Barcelona
Spain Hospital Universitari de Bellvitge L'Hospitalet De Llobregat Barcelona
Spain Parc Taulí Hospital Universitari Sabadell Barcelona
Spain Hospital de l'Esperit Sant Santa Coloma De Gramenet Barcelona
Spain Hospital Joan XXIII Tarragona
Spain Consorci Sanitari de Terrassa Terrassa Barcelona
Spain Hospital de Viladecans Viladecans Barcelona

Sponsors (14)

Lead Sponsor Collaborator
Hospital Universitari Vall d'Hebron Research Institute Consorci Sanitari de Terrassa, Fundació Hospital de l'Esperit Sant, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Germans Trias i Pujol Hospital, Hospital d'Igualada, Hospital de Granollers, Hospital de Mataró, Hospital de Viladecans, Hospital del Mar, Hospital Santa Caterina, Hospital Universitari de Bellvitge, Hospital Universitari Joan XXIII de Tarragona., Parc Taulí Hospital Universitari

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Stress urinary incontinence (SUI). A "Yes" response to any of three questions on the spanish version of the Pelvic Floor Distress Inventory (PFDI) stress incontinence subscale regarding leakage with coughing, sneezing, or laughing; physical exercise; and lifting or bending over (PFDI questions 20, 21 and 22) . 1 year after surgery.
Primary Urgency urinary incontinence (UUI). A "Yes" response to PFDI question 19, "usually experiences urine leakage associated with a feeling of urgency, that is, a strong sensation of needing to go to the bathroom". 1 year after surgery.
Secondary Incontinence severity Both SUI and UII severity will be assessed using the spanish versions of the Sandvik's severity index and the International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF). 1 year after surgery.
Secondary Patients' satisfaction with the procedure. Assessed with the Patient Impression of Improvement (PGI-I) form. 1 year after surgery.
See also
  Status Clinical Trial Phase
Recruiting NCT05534412 - A Practice-Based Intervention To Improve Care for a Diverse Population Of Women With Urinary Incontinence N/A
Recruiting NCT05515198 - Improving Care for Women With Urinary Incontinence (EMPOWER) N/A
Completed NCT04071301 - Collection of Real-life Measurement Data for TENA SmartCare Change Indicator in Subjects With Urinary Incontinence N/A
Completed NCT03623880 - Enhancing Behavioral Treatment for Women With Pelvic Floor Disorders N/A
Recruiting NCT05880862 - Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls Early Phase 1
Recruiting NCT04159467 - Effect of Pelvic Floor Muscle Training on Urinary Incontinence Reports in Obese Women Undergoing a Low Calorie Diet N/A
Completed NCT05485922 - Performance of a Single-use Intermittent Micro-hole Zone Catheter N/A
Completed NCT06268782 - The Effectiveness of an Online Exercise Program on Well-being of Postpartum Women N/A
Not yet recruiting NCT03027986 - Evaluation of a Postural Rehabilitation Program Based on Sensory-motor Control in Men With Urinary Incontinence After Prostatectomy N/A
Recruiting NCT02490917 - ACT™ Balloons Versus Artificial Urinary Sphincter (AMS800™) for the Treatment of Female Stress Urinary Incontinence N/A
Enrolling by invitation NCT02530372 - Feasibility of the UriCap-F for Urine Collection in Hospitalized Women N/A
Enrolling by invitation NCT02529371 - Pre-Marketing Feasibility Evaluation of the UriCap-RM - Urine Collection in Hospitalized Male Patients N/A
Completed NCT02338726 - Pelvic Floor Symptoms and Quality of Life in Elderly Women - a Population-based Pilot Study N/A
Completed NCT02600676 - Transcutaneous Electric Nerve Stimulation (TENS) in Children With Enuresis N/A
Completed NCT02549729 - Effect of the Pelvic Floor Training in Postmenopausal Women With or Without Hormonal Therapy N/A
Completed NCT02239796 - Feasibility Controlled Trial of Tibial Nerve Stimulation for Stroke Related Urinary Incontinence N/A
Completed NCT02368262 - Prevalence of Incontinence and Risk Factors in Children With Cerebral Palsy N/A
Completed NCT01942681 - Female Patients With Signs of uRgE and Stress Urinary Incontinence Study of Propiverine Hydrochloride N/A
Recruiting NCT01804153 - Stem Cells Tratment for the Local Feminine Stress Urinary Incontinence Treatment (HULPURO) Phase 1/Phase 2
Completed NCT01520948 - Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease Phase 3